Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Etienne Chatelut Cecile Arellano |
| Publication date | November 27, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |